TidalSense
8
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
A Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD
Role: collaborator
Utilising Hull Lung Health Study Data to Investigate the Performance of TidalSense Diagnostic Algorithms to Identify COPD and Pre-COPD Among Participants in the FRONTIER Programme.
Role: collaborator
Cardiorespiratory Diagnostic Study
Role: lead
Chronic Obstructive Pulmonary Disease (COPD) Breathing Record Study
Role: lead
COPD Breathing Record Study 2
Role: lead
The Asthma Breathing Record Study
Role: lead
Validation Of Tidal/End -Tidal CO2 in ALS
Role: collaborator
The General Breathing Record Study
Role: lead
All 8 trials loaded